- Home
- DMLP vs ATRC Comparison
DMLP vs ATRC Comparison
Compare DMLP & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMLP
- ATRC
- Stock Information
- Founded
- DMLP 2003
- ATRC 2000
- Country
- DMLP United States
- ATRC United States
- Employees
- DMLP N/A
- ATRC N/A
- Industry
- DMLP Oil & Gas Production
- ATRC Medical/Dental Instruments
- Sector
- DMLP Energy
- ATRC Health Care
- Exchange
- DMLP Nasdaq
- ATRC Nasdaq
- Market Cap
- DMLP 1.5B
- ATRC 1.6B
- IPO Year
- DMLP N/A
- ATRC 2005
- Fundamental
- Price
- DMLP $29.64
- ATRC $32.71
- Analyst Decision
- DMLP
- ATRC Strong Buy
- Analyst Count
- DMLP 0
- ATRC 10
- Target Price
- DMLP N/A
- ATRC $50.40
- AVG Volume (30 Days)
- DMLP 157.9K
- ATRC 618.9K
- Earning Date
- DMLP 05-01-2025
- ATRC 04-30-2025
- Dividend Yield
- DMLP 10.87%
- ATRC N/A
- EPS Growth
- DMLP N/A
- ATRC N/A
- EPS
- DMLP 2.13
- ATRC N/A
- Revenue
- DMLP $154,639,000.00
- ATRC $465,307,000.00
- Revenue This Year
- DMLP N/A
- ATRC $14.60
- Revenue Next Year
- DMLP N/A
- ATRC $12.66
- P/E Ratio
- DMLP $13.99
- ATRC N/A
- Revenue Growth
- DMLP N/A
- ATRC 16.55
- 52 Week Low
- DMLP $28.25
- ATRC $18.94
- 52 Week High
- DMLP $35.74
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- DMLP 38.36
- ATRC 29.68
- Support Level
- DMLP $29.29
- ATRC $32.78
- Resistance Level
- DMLP $30.48
- ATRC $39.71
- Average True Range (ATR)
- DMLP 0.84
- ATRC 1.62
- MACD
- DMLP -0.02
- ATRC -0.81
- Stochastic Oscillator
- DMLP 44.27
- ATRC 0.99
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.